Precefi is proud to represent some of the most experienced and FDA-tested dermatology sites in the country, including two with Phase I capabilities. Additionally, Precefi has partnered with a leader in precision medicine to enable the minimally invasive collection of skin samples from sites of inflammation using an FDA-registered device.

Our patient app is another key asset, designed to enhance compliance and provide real-time patient data during your study